Previous close | 31.55 |
Open | 31.56 |
Bid | N/A x N/A |
Ask | N/A x N/A |
Day's range | 31.41 - 32.05 |
52-week range | 18.68 - 32.36 |
Volume | |
Avg. volume | 1,369 |
Market cap | N/A |
Beta (5Y monthly) | 0.81 |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | 06 Aug 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Key Insights Given the large stake in the stock by institutions, Organon's stock price might be vulnerable to their...
Organon (OGN) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
JERSEY CITY, N.J., July 09, 2024--Organon will report Q2 2024 results and host conference call on August 6, 2024. Organon estimates $15M milestone expenses in second quarter.